HEADER NEUROPEPTIDE 26-OCT-06 2NOR TITLE SOLUTION STRUCTURE OF NK1 AGONIST PHYLLOMEDUSIN BOUND TO DPC MICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHYLLOMEDUSIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED KEYWDS HELIX, 3-10 HELIX, LIPID INDUCED CONFORMATION, DPC MICELLES, KEYWDS 2 NEUROPEPTIDE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.DIKE,S.M.COWSIK REVDAT 5 30-OCT-24 2NOR 1 REMARK REVDAT 4 27-DEC-23 2NOR 1 REMARK REVDAT 3 25-DEC-19 2NOR 1 REMARK SEQRES LINK REVDAT 2 24-FEB-09 2NOR 1 VERSN REVDAT 1 06-NOV-07 2NOR 0 JRNL AUTH A.DIKE,S.M.COWSIK JRNL TITL SOLUTION STRUCTURE OF NK1 AGONIST PHYLLOMEDUSIN BOUND TO DPC JRNL TITL 2 MICELLES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5, DYANA 1.5 REMARK 3 AUTHORS : GUNTERT, P. ET AL. (DYANA), GUNTERT, P. ET AL. REMARK 3 (DYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NOR COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-OCT-06. REMARK 100 THE DEPOSITION ID IS D_1000040121. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 305 REMARK 210 PH : 4.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 5.1 MM PHYLLOMEDUSIN, 195 MM REMARK 210 PERDEUTERATED DPC, 90%H2O, 10% REMARK 210 D2O, PH 4.5 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.1 REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING (DYANA) REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 8 PRO A 3 43.51 -75.01 REMARK 500 9 PRO A 3 43.56 -75.04 REMARK 500 10 PRO A 3 43.58 -75.01 REMARK 500 11 PRO A 3 43.52 -75.01 REMARK 500 12 PRO A 3 43.54 -74.94 REMARK 500 13 PRO A 3 43.52 -74.93 REMARK 500 14 PRO A 3 43.53 -74.96 REMARK 500 15 PRO A 3 43.56 -74.96 REMARK 500 16 PRO A 3 43.54 -75.00 REMARK 500 17 PRO A 3 43.58 -75.03 REMARK 500 18 PRO A 3 43.58 -75.01 REMARK 500 19 PRO A 3 40.72 -75.00 REMARK 500 20 PRO A 3 43.57 -74.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2NOU RELATED DB: PDB DBREF 2NOR A 1 10 PDB 2NOR 2NOR 1 10 SEQRES 1 A 10 PCA ASN PRO ASN ARG PHE ILE GLY LEU MET MODRES 2NOR PCA A 1 GLN PYROGLUTAMIC ACID HET PCA A 1 14 HETNAM PCA PYROGLUTAMIC ACID FORMUL 1 PCA C5 H7 N O3 HELIX 1 1 ASN A 2 PHE A 6 5 5 LINK C PCA A 1 N ASN A 2 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 N PCA A 1 -9.199 4.435 7.403 1.00 0.00 N HETATM 2 CA PCA A 1 -9.091 5.051 6.094 1.00 0.00 C HETATM 3 CB PCA A 1 -9.288 6.558 6.348 1.00 0.00 C HETATM 4 CG PCA A 1 -8.967 6.721 7.839 1.00 0.00 C HETATM 5 CD PCA A 1 -9.131 5.318 8.395 1.00 0.00 C HETATM 6 OE PCA A 1 -9.277 5.075 9.590 1.00 0.00 O HETATM 7 C PCA A 1 -7.736 4.751 5.444 1.00 0.00 C HETATM 8 O PCA A 1 -7.577 4.952 4.241 1.00 0.00 O HETATM 9 H1 PCA A 1 -9.363 3.447 7.531 1.00 0.00 H HETATM 10 HA PCA A 1 -9.887 4.678 5.447 1.00 0.00 H HETATM 11 HB2 PCA A 1 -8.653 7.186 5.720 1.00 0.00 H HETATM 12 HB3 PCA A 1 -10.339 6.809 6.185 1.00 0.00 H HETATM 13 HG2 PCA A 1 -7.931 7.039 7.969 1.00 0.00 H HETATM 14 HG3 PCA A 1 -9.646 7.426 8.317 1.00 0.00 H